We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
This guidance relates to the legal criteria for determining whether a building is considered a higher-risk building under the Building Safety Act 2022 and the Higher-Risk Buildings (Descriptions and Supplementary Provisions) Regulations 2023. It relates to the definition of higher-risk...
Use these general provisions to help you determine the origin of your products.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Northern Region Judge J White and Member Ms SD Latham sitting on 10 February 2020
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
First-Tier Property Tribunal Decision of Mr Anthony Harris LLM FRICS FCIArb dated 12/03/2024
Southern Region, Mr D Banfield FRICS on 12 May 2021
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).